UF awards tenure or promotion to six College of Pharmacy faculty
The faculty were recognized for their contributions to the University of Florida, their profession and society.
The faculty were recognized for their contributions to the University of Florida, their profession and society.
The National Institute of General Medical Sciences awarded a five-year, $800,500 grant to establish the “Chemistry-Biology Interface Training Program at the University of Florida.”
Robert Huigens, Ph.D., an assistant professor of medicinal chemistry, has re-engineered the structure of vincamine, a plant-derived compound and administered it to mice, successfully reducing their morphine-seeking behaviors. The American Chemical Society featured the study on the May cover of the Journal of Medicinal Chemistry.
Kava’s reputation in preventing cancer just received a boost from the American Association for Cancer Prevention. The May cover of the organization’s flagship journal, Cancer Prevention Research, featured a clinical study on kava led by Chengguo “Chris” Xing, Ph.D., a professor of medicinal chemistry and the Frank A. Duckworth Eminent Scholar Chair at the UF College of Pharmacy.
Alumni and graduate students who worked under Luesch’s mentorship came from across the world to present at the Gordon Research Conference on Marine Natural Products.
Researchers from the University of Florida College of Pharmacy have discovered a safer and more effective anticancer drug to target leukemia, lymphoma, and breast and lung cancers. The journal Nature Medicine published the findings this month.
Drs. Guangrong Zheng, left, and Daohong Zhou, right, collaborate closely on anti-aging research. The scientific team of Daohong Zhou, Ph.D., a professor of pharmacodynamics, and Guangrong Zheng, Ph.D., an associate professor of medicinal…
Researchers in the UF College of Pharmacy teamed with collaborators in Singapore to study a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
The American Chemical Society, or ACS, has appointed Jane Aldrich, Ph.D., as a fellow. ACS will honor Aldrich, along with the rest of its 2019 fellows — a cohort of 70 from organizations as diverse as GlaxoSmithKline, NASA and Massachusetts Institute of Technology — at its National Meeting &…
Recent reports of babies born with opioid withdrawal symptoms after their mothers used kratom during pregnancy have generated much concern about the medicinal.